Ocrelizumab lowers risk of upper limb disability progression in PPMS patients #ECTRIMS
Upper limb (UL) function impairment is prevalent among patients with primary progressive multiple sclerosis (PPMS) and alters a patient’s quality of life. Researchers set out to evaluate the effect of Ocrelizumab on upper limb function using the nine-hole peg test (9HPT)...Read more - http://www.ms-uk.org/ocrelizumab-lowers ... ts-ectrims
Ocrelizumab lowers risk of upper limb disability progression
Ocrelizumab lowers risk of upper limb disability progression
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1532 Views
-
Last post by NHE
-
- 1 Replies
- 1085 Views
-
Last post by NHE
-
- 0 Replies
- 1311 Views
-
Last post by NHE
-
- 4 Replies
- 1342 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1040 Views
-
Last post by NHE
-
- 0 Replies
- 11211 Views
-
Last post by NHE
-
- 0 Replies
- 1125 Views
-
Last post by NHE
-
- 0 Replies
- 2513 Views
-
Last post by NHE
-
- 0 Replies
- 1482 Views
-
Last post by NHE